U.S. Preventive Services Task Force: Prostate Cancer Final Recommendation Statement

U.S. Preventive Services Task Force: Prostate Cancer Final Recommendation Statement

Prostate Cancer: Genomics & Screening

CDC information: Prostate cancer screening- A prostate specific antigen (PSA) test may find a prostate health problem, but treatment can cause serious side effects. Learn about prostate cancer and talk to your doctor before you decide to get tested or treated for prostate cancer

The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer

Talking to men about PSA testing,  by Barak Gaster, New York Times, Aug 19  

CDC information: Risk factors for prostate cancer include genetics and family history

NCI information: Genetics of prostate cancer (PDQ)

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.

Al Olama AA, et al. Nat Genet. 2014 Sep 14

New genetic variants indicate risk for prostate cancer: international study, Medical News Today, Sep 17

Did you know? 995 genes have been reported in relation to prostate cancer risk and outcomes, including 81 genomewide association studies. To find out more, visit the HuGE Navigator

Incorporating genomics into breast and prostate cancer screening: assessing the implications.

Susmita Chowdhury MD, MPhil et al. Genetics in Medicine, 2013

U.S. Preventive Services Task Force: Prostate Cancer Final Recommendation Statement